Format

Send to

Choose Destination
Blood Cancer J. 2019 Jan 24;9(2):11. doi: 10.1038/s41408-018-0167-3.

A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy.

Author information

1
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. gangat.naseema@mayo.edu.
2
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
3
Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.
4
Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.
PMID:
30679417
PMCID:
PMC6345855
DOI:
10.1038/s41408-018-0167-3
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center